Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials
Jun 14, 2018 Picture: SYDNEY, AUS - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. The CMUH is a 2,054-bed facility with a dedicated Clinical Trials Centre (CTC). The CMUH deal is designed to give Novotech clients: - Faster start-up times - Access to the CMUH patient database - World-class clinical research - regulatory compliance with FDA, PMDA and EMEA - Outstanding recruiters across many therapeutic areas: breast cancer, lung cancer, colorectal cancer, Hepatitis, SLE, RA, Stroke, Diabetes, etc. - Leading principal investigators The CTC of CMUH was established in 2008 and has been led by distinguished Professor Chung Y. Hsu since 2010. According to the CTC, Professor Hsu's management principle is to deliver international standard clinical research to facilitate market...
If you wish to read the full news article, Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials, simply click on
'Read full story' below, but give us a 'LIKE' or share 1st